Search Login Register
3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid
(CPP)
Summary
1108
relevant articles (67 outcomes,
153 trials/studies)
found for this Bio-Agent
Description:
structure given in first source; NMDA receptor antagonist
Also Known As:
CPP; 3-2-CPP; 4-(3-phosphonopropyl)-2-piperazinecarboxylic acid
Key Diseases for which 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid is
Relevant
-
Pelvic Pain
:
8 outcomes 24 studies in 125 results
-
Ischemia
:
6 outcomes 5 studies in 41 results
-
Pain (Aches)
:
5 outcomes 14 studies in 87 results
-
Craniocerebral Trauma (Head Injury)
:
4 outcomes 15 studies in 86 results
-
Wounds and Injuries (Trauma)
:
4 outcomes 3 studies in 28 results
Show All >>
Drugs Related to 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid
-
N-Methylaspartate (NMDA)
-
maleic acid (maleate)
-
Gonadotropin-Releasing Hormone (GnRH)
-
Morphine (MS Contin)
-
Dextrorphan
-
Dizocilpine Maleate (Dizocilpine)
-
Carbon Monoxide
-
Ketamine
-
Epinephrine (Adrenaline)
-
selfotel
Show All >>
Therapies Related to 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid
-
Cardiopulmonary Resuscitation (CPR)
-
Resuscitation
-
Intensive Care (Surgical Intensive Care)
-
Artificial Respiration (Mechanical Ventilation)
-
Hemodilution
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2008 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.